Circ_16601 facilitates Hippo pathway signaling via the miR-5580-5p/FGB axis to promote my-CAF recruitment in the TME and LUAD progression

Respir Res. 2023 Nov 12;24(1):276. doi: 10.1186/s12931-023-02566-4.

Abstract

Background: Lung cancer represents a significant public health issue in China, given its high incidence and mortality rates. Circular RNAs (circRNAs) have been recently proposed to participate in the development and progression of tumors. Nevertheless, their particular roles in the pathogenesis of lung adenocarcinoma (LUAD), the tumor microenvironment (TME), and the underlying molecular mechanisms are still not well understood.

Methods: High-throughput sequencing was used to analyze the circRNAs expression profiles in 7 pairs of human LUAD tissues. shRNA was used to knockdown the YAP1 and FGB genes. RNA sequencing and RT-qPCR were performed to classify the regulatory effects of circ_16601 in LUAD cells. The progression effect of circ_16601 on lung cancer was investigated in vitro and in vivo.

Results: The circ_16601 is significantly elevated in LUAD tissues compared to adjacent normal lung tissues, and its high expression is positively associated with poor prognosis in LUAD patients. Additionally, circ_16601 overexpression promotes LUAD cell proliferation in vitro and increases xenograft tissue growth in mice in vivo; circ_16601 also could recruit fibroblasts to cancer associate fibroblasts. Mechanistically, circ_16601 can directly bind to miR-5580-5p, preventing its ability to degrade FGB mRNA and enhancing its stability. Subsequently, circ_16601 promotes the activation of the Hippo pathway in a YAP1-dependent manner, leading to LUAD progression.

Conclusions: Our findings shed valuable insights into the regulatory role of circ_16601 in LUAD progression and highlight its potential as a diagnostic and therapeutic target in LUAD. Overall, this study provides theoretical support to improve the prognosis and quality of life of patients suffering from this devastating disease.

Keywords: Circ_16601; FGB; HIPPO pathway; LUAD; My-CAF; miR-5580-5p.

MeSH terms

  • Adenocarcinoma of Lung* / genetics
  • Animals
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Fibrinogen
  • Hippo Signaling Pathway*
  • Humans
  • Lung Neoplasms* / genetics
  • Mice
  • MicroRNAs* / genetics
  • RNA, Circular* / genetics
  • Tumor Microenvironment

Substances

  • FGB protein, human
  • Fibrinogen
  • MicroRNAs
  • RNA, Circular